Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1522-1528

  Zhao, Ying Lan ^a   Cen, Xiao Bo ^a   Ito, Masafumi ^a   Yokoyama, Keiko ^a   Takagi, Kenji ^a   Kitaichi, Kiyoyuki ^a   Nadai, Masayuki ^a   Ohta, Michio ^a   Takagi, Kenzo ^a   Hasegawa, Takaaki ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ANTIBIOTIC AGENT; BACTERIAL TOXIN; GREPAFLOXACIN; INULIN; LEVOFLOXACIN; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PENTOXIFYLLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGA TOXIN; THIOUREA DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG URINE LEVEL; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY CLEARANCE; KIDNEY PLASMA FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; ESCHERICHIA COLI O157; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; OFLOXACIN; P-GLYCOPROTEIN; RATS; RATS, WISTAR; SHIGA-LIKE TOXIN II;

EID: 0036241812     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1522-1528.2002     Document Type: Article

References (39)

1. Chromatographic estimation of iothalamate and p-aminohippuric acid to measure glomerular filtration rate and effective renal plasma flow in humans
2. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine 123 in rats
3. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice
4. Cytotoxic activity of Escherichia coli O157:H7 culture filtrate on the mouse colon and kidney
5. Interaction of P-glycoprotein with a hydrophobic component of rat urine
6. Anti-tumor necrosis factor properties on non-peptide drugs in acute-phase responses
7. A new spectrophotometric method for the detection and determination of keto sugars and trioses
8. Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis
9. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats
10. Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds
11. Expression and function of P-glycoprotein in rats with glycerolinduced acute renal failure
12. Modulators of the multidrug transporter, P-glycoprotein, exist in the human plasma
13. Effect of antibiotics, LVFX and fosfomycin, on a mouse model with Escherichia coli O157 infection
14. Distribution characteristics of LVFX and grepafloxacin in rat kidney
15. The interaction and transport of β-lactam antibiotics with the cloned rat renal organic anion transporter 1
16. Infection by verocytotoxin-producing Escherichia coli
17. Shiga toxin-associated hemolytic-uremic syndrome: Interleukin-1β enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro
18. Decreased antipyrine clearance following endotoxin administration: In vivo evidence of the role of nitric oxide
19. Reactive oxygen species as a risk factor in verotoxin-1-exposed rats
20. Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats
21. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS)
22. Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats
23. Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice
24. Shiga and Shiga-like toxins
25. Colonic hemorrhage produced in mice by a unique Vero cell cytotoxin from an Escherichia coli strain that causes hemorrhagic colitis
26. The histopathology of the hemolytic uremic syndrome associated with verocyto-toxin-producing Escherichia coli infections
27. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats
28. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat
29. Expression, cloning, and characterization of a novel multispecific organic anion transporter
30. Expression, cloning, and characterization of rOAT1
31. Plasma, urinary, and erythrocyte concentrations of guanidine compounds in patients with chronic renal failure
32. Comparison of the relative toxicities of Shiga-like toxins type I and II for mice
33. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages
34. Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classic renal organic anion p-ammohippurate
35. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7
36. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
37. The effect of lipopolysaccharide on the disposition of xanthines in rats
38. Evaluation of renal tubular secretion and reabsorption of LVFX in rats
39. Possible involvement of P-glycoprotein on biliary excretion of grepafloxacin